Analysis of hepatic expression of genes involved in lipid and iron metabolism in nonalcoholic fatty liver disease

被引：0
|
作者：
Mitsuyoshi, Hironori
Yasui, Kohichiroh
Harano, Yuichi
Itoh, Yoshito
Okanoue, Takeshi
机构：
[1] Kyoto Prefectural Univ Med, Kyoto, Japan
[2] Akashi City Hosp, Akashi, Hyogo, Japan
[3] Saiseikai Suita Hosp, Suita, Osaka, Japan
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1115
引用
收藏
页码：733A / 733A
页数：1
相关论文
共 50 条
  • [21] The Link Between Hepatic Vitamin A Metabolism and Nonalcoholic Fatty Liver Disease
    Chen, Guoxun
    CURRENT DRUG TARGETS, 2015, 16 (12) : 1281 - 1292
  • [22] Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
    Zhao, Li
    Cang, Zhen
    Sun, Honglin
    Nie, Xiaomin
    Wang, Ningjian
    Lu, Yingli
    BMC ENDOCRINE DISORDERS, 2017, 17 : 13
  • [23] Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
    Li Zhao
    Zhen Cang
    Honglin Sun
    Xiaomin Nie
    Ningjian Wang
    Yingli Lu
    BMC Endocrine Disorders, 17
  • [24] Biomarkers and subtypes of deranged lipid metabolism in nonalcoholic fatty liver disease
    José M Mato
    Cristina Alonso
    Mazen Noureddin
    Shelly C Lu
    World Journal of Gastroenterology, 2019, (24) : 3009 - 3020
  • [25] Genes and Nonalcoholic Fatty Liver Disease
    de Alwis, Nimantha Mark Wilfred
    Day, Christopher Paul
    CURRENT DIABETES REPORTS, 2008, 8 (02) : 156 - 163
  • [26] Genes and nonalcoholic fatty liver disease
    Nimantha Mark Wilfred de Alwis
    Christopher Paul Day
    Current Diabetes Reports, 2008, 8 : 156 - 163
  • [27] Impaired hepatic lipid metabolism and biomarkers in fatty liver disease
    Teixeira, Francisca S.
    Pimentel, Ligia L.
    Pintado, Manuela E.
    Rodriguez-Alcala, Luis M.
    BIOCHIMIE, 2023, 215 : 69 - 74
  • [28] Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease
    Ma, Yuting
    Kan, Chengxia
    Qiu, Hongyan
    Liu, Yongping
    Hou, Ningning
    Han, Fang
    Shi, Junfeng
    Sun, Xiaodong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis
    Huang, Rongshuang
    Guo, Fan
    Li, Yanping
    Liang, Yan
    Li, Guobo
    Fu, Ping
    Ma, Liang
    PHYTOMEDICINE, 2021, 92
  • [30] A nonalcoholic fatty liver disease cirrhosis model in gerbil: the dynamic relationship between hepatic lipid metabolism and cirrhosis
    Li, Wei
    Guan, Zheng
    Brisset, Jean C.
    Shi, Qiaojuan
    Lou, Qi
    Ma, Yue
    Suriguga, Su
    Ying, Huazhong
    Sa, Xiaoying
    Chen, Zhenwen
    Quax, Wim J.
    Chu, Xiaofeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (01): : 146 - +
12345